Table 2. Captures of primary RVFV mosquito vectors (Ae. mcintoshi and Ae. ochraceus) recorded at different optimal synthetic component doses and a blend in 9 replicate field trials.
Aldehyde treatments | Number caught | IRR (95% CI) | P-values |
Blend A | 104 | 1.30 (0.70–2.43) | 0.408 |
Blend B | 85 | 1.06 (0.57–2.00) | 0.850 |
Blend C | 96 | 1.20 (0.64–2.24) | 0.567 |
Blend D | 88 | 1.10 (0.59–2.06) | 0.766 |
Blend E | 91 | 1.14 (0.61–2.13) | 0.686 |
Blend F | 258 | 3.23 (1.76–5.91) | <0.001 |
2 Heptanal | 129 | 1.61 (0.87–2.99) | 0.128 |
0.5 Octanal | 107 | 1.34 (0.72–2.49) | 0.358 |
0.1 Nonanal | 115 | 1.44 (0.77–2.67) | 0.250 |
0.1 Decanal | 109 | 1.36 (0.73–2.54) | 0.328 |
Incidence rate ratio (IRR) and corresponding 95% confidence interval (CI) and P-values; P-values based on comparison to CO2 following generalized linear model (GLM) with negative binomial error structure and log link in R 2.11.0 software; number in front of each compound represents the optimal dose of each component evaluated in mg/ml.